Maturity assessment and curve progression in girls with idiopathic scoliosis

Journal of Bone and Joint Surgery

Volumn 89, Issue 1, 2007, Pages 64-73

  Sanders, James O ^a   Browne, Richard H ^b   McConnell, Sharon J ^a   Margraf, Susan A ^a   Cooney, Timothy E ^c   Finegold, David N ^d  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b TEXAS SCOTTISH RITE HOSPITAL FOR CHILDREN   (United States)

^c HAMOT MEDICAL CENTER   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; ESTRADIOL; GROWTH FACTOR; OSTEOCALCIN;

ANTHROPOMETRY; ARTICLE; BONE MATURATION; CHILD; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; GROWTH ACCELERATION; HUMAN; HUMAN EXPERIMENT; IDIOPATHIC SCOLIOSIS; MEASUREMENT; METACARPAL BONE; NORMAL HUMAN; OUTCOME ASSESSMENT; PHALANX; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SEXUAL MATURATION; SPINE RADIOGRAPHY; WEIGHT CHANGE;

EID: 33846056069     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/JBJS.F.00067     Document Type: Article

References (53)

1. Tanner JM. Some main features of normal growth in children. In: Zorab PA, editor. Scoliosis and growth: proceedings of a third symposium held at the Institute of Diseases of the Chest, Brompton Hospital, London, on 13th November, 1970. Edinburgh: Churchill Livingstone; 1971. p 14-28.
2. Tanner JM, Davies PS. Clinical longitudinal standards for height and height velocity for North American children. J Pediatr. 1985;107:317-29.
3. Gruelich WW, Pyle SI. Radiographic atlas of skeletal development of the hand and wrist. 2nd ed. Stanford, CA: Stanford University Press; 1959.
4. Tanner JM. Assessment of skeletal maturity and prediction of adult height (TW3 method). 3rd ed. London: WB Saunders; 2001.
5. Sanders JO, Herring JA, Browne RH. Posterior arthrodesis and instrumentation in the immature (Risser-grade-0) spine in idiopathic scoliosis. J Bone Joint Surg Am. 1995;77:39-45.
6. Acheson RM. The Oxford method of assessing skeletal maturity. Clin Orthop. 1957;10:19-39.
7. Tanner JM. Growth and endocrinology of the adolescent. In: Gardner LI, editor. Endocrine and genetic diseases of childhood. 2nd ed. Philadelphia: WB Saunders; 1974. p 14.
8. Lenke LG, Betz RR, Harms J, Bridwell KH, Clements DH, Lowe TG, Blanke K. Adolescent idiopathic scoliosis: a new classification to determine extent of spinal arthrodesis. J Bone Joint Surg Am. 2001;83:1169-81.
9. Izumi Y. The accuracy of Risser staging. Spine. 1995;20:1868-71.
10. Dimeglio A, Charles YP, Daures JP, de Rosa V, Kabore B. Accuracy of the Sauvegrain method in determining skeletal age during puberty. J Bone Joint Surg Am. 2005;87:1689-96.
11. Duval-Beaupere G. Pathogenic relationship between scoliosis and growth. In: Zorab PA, editor. Scoliosis and growth: proceedings of a third symposium held at the Institute of Diseases of the Chest, Brompton Hospital, London, on 13th November, 1970. Edinburgh: Churchill Livingstone; 1971. p 58-64.
12. Burwell RG. The relationship between scoliosis and growth. In: Zorab PA, editor. Scoliosis and growth: proceedings of a third symposium held at the Institute of Diseases of the Chest, Brompton Hospital, London, on 13th November, 1970. Edinburgh: Churchill Livingstone; 1971. p 131-50.
13. Calvo IJ. Observations on the growth of the female adolescent spine and its relation to scoliosis. Clin Orthop. 1957;10:40-7.
14. Dimeglio A, Bonnel F. Le rachis en croissance. Paris: Springer; 1990.
15. Duval-Beaupere G. Les reperes de maturation dans la surveillance des scolioses. [Maturation indices in the surveillance of scoliosis]. Rev Chir Reparatrice Appar Mot. 1970;56:59-76.
16. Heine J, Reher H. Die progredienz der unbehandelten Skoliose nach poliomyelitis bis wachstumsabschluB. [Progress of untreated scoliosis following poliomyelitis up to the end of the growth-period (author's transl)]. Z Orthop Ihre Grenzgeb 1975;113:876-9.
17. Hopf C, Sandt E, Heine J. Die progredienz unbehandelter idiopathischer skoiosen im rontgenbild. [The progression of untreated idiopathic scoliosis in the x-ray image]. Rofo. 1989;151:311-6.
18. Little DG, Song KM, Katz D, Herring JA. Relationship of peak height velocity to other maturity indicators in idiopathic scoliosis in girls. J Bone Joint Surg Am. 2000;82:685-93.
19. Song KM, Little DG. Peak height velocity as a maturity indicator for males with idiopathic scoliosis. J Pediatr Orthop. 2000;20:286-8.
20. Loncar-Dusek M, Pecina M, Prebeg Z. A longitudinal study of growth velocity and development of secondary gender characteristics versus onset of idiopathic scoliosis. Clin Orthop Relat Res. 1991;270:278-82.
21. Risser JC. The Iliac apophysis: an invaluable sign in the management of scoliosis. Clin Orthop. 1958;11:111-9.
22. Goldberg CJ, Fogarty EE, Moore DP, Dowling FE. Scoliosis and developmental theory: adolescent idiopathic scoliosis. Spine. 1997;22:2228-38.
23. Goldberg CJ, Dowling FE, Fogarty EE, Moore DP. Adolescent idiopathic scoliosis as developmental instability. Genetica. 1995;96:247-55.
24. Sanders JO, Browne RH, Cooney TE, Finegold DN, McConnell SJ, Margraf SA. Correlates of the peak height velocity (PHV) in girls with idiopathic scoliosis. Spine. 2006;31:2289-95.
25. Rotteveel J, de Ridder C, Schoute E, Delemarre-van de Waal HA. Androstenedione, dehydroepiandrosterone sulfate, and estradiol levels throughout female puberty: relation to height velocity. Horm Res. 1997;48:263-7.
26. Lashansky G, Saenger P, Fishman K, Gautier T, Mayes D, Berg G, Di Martino-Nardi J, Reiter E. Normative data for adrenal steroidogenesis in a healthy pediatric population: age- and sex-related changes after adrenocorticotropin stimulation. J Clin Endocrinol Metab. 1991;73:674-86.
27. Reiter EO, Fuldauer VG, Root AW. Secretin of the adrenal androgen, dehydroepiandrosterone sulfate, during normal infancy, childhood, and adolescence, in sick infants, and in children with endocrinologic abnormalities. J Pediatr. 1977;90:766-70.
28. Kasa-Vubu JZ, Padmanabhan V, Kletter GB, Brown MB, Reiter EO, Sizonenko PC, Beitins IZ. Serum bioactive luteinizing and follicle-stimulating hormone concentrations in girls increase during puberty. Pediatr Res. 1993;34:829-33.
29. Blumsohn A, Hannon RA, Wrate R, Barton J, al-Dehaimi AW, Colwell A, Eastell R. Biochemical markers of bone turnover in girls during puberty. Clin Endocrinol (Oxf). 1994;40:663-70.
30. Grumbach MM. Onset of puberty. In: Berenberg SR, editor. Puberty, biologic and social components. Leiden: HE Stenfert Kroese; 1975. p 1-21.
31. Grumbach MM. The neuroendocrinology of human puberty revisited. Horm Res. 2002;57 Suppl 2:2-14.
32. Grumbach MM. Estrogen, bone, growth and sex: a sea change in conventional wisdom. J Pediatr Endocrinol Metab. 2000;13 Suppl 6:1439-55.
33. Grumbach MM. The role of estrogen in the male and female: evidence from mutations in synthesis and action. Horm Res. 2000;53 Suppl 3:23-4.
34. Reiter EO. Neuroendocrine control processes. Pubertal onset and progression. J Adolesc Health Care. 1987;8:479-91.
35. Nilsson O, Chrysis D, Pajulo O, Boman A, Holst M, Rubinstein J, Martin Ritzen E, Savendahl L. Localization of estrogen receptors-alpha and -beta and androgen receptor in the human growth plate at different pubertal stages. J Endocrinol. 2003;177:319-26.
36. Cutler GB Jr. The role of estrogen in bone growth and maturation during childhood and adolescence. J Steroid Biochem Mol Biol. 1997;61:141-4. 37. Styne DM. The regulation of pubertal growth. Horm Res. 2003;60(Suppl 1):22-6.
37. Lee PA, Witchel SF. The influence of estrogen on growth. Curr Opin Pediatr. 1997;9:431-6.
38. Bala RM, Lopatka J, Leung A, McCoy E, McArthur RG. Serum immunoreactive somatomedin levels in normal adults, pregnant women at term, children at various ages, and children with constitutionally delayed growth. J Clin Endocrinol Metab. 1981;52:508-12.
39. Grumbach MM, Styne DM. Puberty: ontogeny, neuroendocrinology, physiology, and disorders. In: Williams RH, Wilson JD, Foster DW, editors. Williams' textbook of endocrinology. 8th ed. Philadelphia: WB Saunders; 1992. p 1139-221.
40. Hesse V, Jahreis G, Schambach H, Vogel H, Vilser C, Seewald HJ, Borner A, Deichl A. Insulin-like growth factor I correlations to changes of the hormonal status in puberty and age. Exp Clin Endocrinol. 1994;102:289-98.
41. Juul A, Dalgaard P, Blum WF, Bang P, Hall K, Michaelsen KF, Muller J, Skakkebaek NE. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab. 1995;80:2534-42.
42. Rosenfield RI, Furlanetto R, Bock D. Relationship of somatomedin-C concentrations to pubertal changes. J Pediatr. 1983;103:723-8.
43. Delemarre-van de Waal HA, van Coeverden SC, Rotteveel J. Hormonal determinants of pubertal growth. J Pediatr Endocrinol Metab. 2001;14 Suppl 6: 1521-6.
44. Rotteveel J, Schoute E, Delemarre-van de Waal HA. Serum procollagen I carboxyterminal propeptide (PICP) levels through puberty: relation to height velocity and serum hormone levels. Acta Paediatr. 1997;86:143-7.
45. Crofton PM, Stirling HF, Kelnar CJ. Bone alkaline phosphatase and height velocity in short normal children undergoing growth-promoting treatments: longitudinal study. Clin Chem. 1995;41:672-8.
46. Crofton PM, Stirling HF, Schonau E, Kelnar CJ. Bone alkaline phosphatase and collagen markers as early predictors of height velocity response to growth-promoting treatments in short normal children. Clin Endocrinol (Oxf). 1996;44:385-94.
47. Izumi Y. Alkaline phosphatase as a biochemical maturity index in female adolescence. Spine. 1993;18:2257-60.
48. Willner S, Johnell O. Study of biochemical and hormonal data in idiopathic scoliosis in girls. Arch Orthop Trauma Surg. 1981;98:251-5.
49. Zorab PA. Total hydroxyproline excretion in scoliosis. In: Zorab PA, editor. Proceedings of a second symposium on scoliosis: causation. Edinburgh: E and S Livingston; 1968.
50. Zorab PA, Clark S, Harrison A, Seel JR. Hydroxyproline excretion and height velocity in adolescent boys. Arch Dis Child. 1970;45:763-5.
51. Johansen JS, Giwercman A, Hartwell D, Nielsen CT, Price PA, Christiansen C, Skakkebaek NE. Serum bone Gla-protein as a marker of bone growth in children and adolescents: correlation with age, height, serum insulin-like growth factor I, and serum testosterone. J Clin Endocrinol Metab. 1988;67:273-8.
52. Johansen JS, Jensen SB, Riis BJ, Rasmussen L, Zachmann M, Christiansen C. Serum bone Gla protein: a potential marker of growth hormone (GH) deficiency and the response to GH therapy. J Clin Endocrinol Metab. 1990;71:122-6.
53. Vihervuori E, Turpeinen M, Siimes MA, Koistinen H, Sorva R. Collagen formation and degradation increase during growth hormone therapy in children. Bone. 1997;20:133-8.